View Older Stories View More Recent Stories

Jun 1, 2021 04:00PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2021 07:34AM Cytokinetics (CYTK) and The ALS Association Renew Partnership to Advance the Fight Against ALS
May 19, 2021 07:30AM Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS
May 17, 2021 08:12AM Cytokinetics (CYTK) Announces Secondary Analysis of GALACTIC-HF Presented in Late Breaking Clinical Trial Session at ACC
May 17, 2021 08:00AM Cytokinetics Announces Secondary Analysis of GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the American College of Cardiology 70th Annual Scientific Session and Published in the Jou
May 16, 2021 08:00AM Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session
May 10, 2021 04:00PM Cytokinetics Announces Three Upcoming Presentations Related to Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session
May 6, 2021 04:00PM Cytokinetics Reports First Quarter 2021 Financial Results
May 6, 2021 07:30AM Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing REDWOOD-HCM
May 5, 2021 04:00PM Cytokinetics to Hold Annual Meeting of Stockholders
May 4, 2021 07:30AM Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment
May 3, 2021 04:00PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 22, 2021 04:00PM Cytokinetics to Announce First Quarter Results on May 6, 2021
Apr 12, 2021 07:35AM Cytokinetics (CYTK) Announces Preclinical Data for CK-3773274 Presented at American Chemical Society Meeting
Apr 12, 2021 07:30AM Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Chemical Society Spring 2021 Virtual Meeting
Apr 5, 2021 04:00PM Cytokinetics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Apr 2, 2021 04:00PM Cytokinetics Announces Preclinical Data for CK-3773274 to be Presented at the American Chemical Society Spring 2021 Virtual Meeting
Apr 1, 2021 04:00PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 18, 2021 07:33AM Cytokinetics (CYTK) Announces Secondary Analysis From GALACTIC-HF to Be Presented in Late Breaking Clinical Trial Session at ACC.21
Mar 18, 2021 07:30AM Cytokinetics Announces Secondary Analysis From GALACTIC-HF to Be Presented in Late Breaking Clinical Trial Session at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)
Mar 2, 2021 04:00PM Cytokinetics to Participate in Upcoming Investor Conferences
Feb 26, 2021 04:32PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 26, 2021 07:30AM Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
Feb 25, 2021 04:00PM Cytokinetics Reports Fourth Quarter 2020 Financial Results
Feb 18, 2021 08:20AM Cytokinetics (CYTK) Adds Muna Bhanji to Board
Feb 18, 2021 07:30AM Cytokinetics Names Muna Bhanji to Board of Directors
Feb 11, 2021 04:00PM Cytokinetics to Announce Fourth Quarter Results on February 25, 2021
Feb 2, 2021 07:30AM Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants
Feb 1, 2021 04:00PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 13, 2021 07:30AM Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM
Jan 11, 2021 07:37AM Cytokinetics (CYTK) Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy
Jan 11, 2021 07:30AM Cytokinetics Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy
Jan 6, 2021 04:00PM Cytokinetics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
Dec 23, 2020 07:33AM Cytokinetics (CYTK) Regains European Rights to Omecamtiv Mecarbil
Dec 23, 2020 07:30AM Cytokinetics Regains European Rights to Omecamtiv Mecarbil
Dec 14, 2020 07:30AM Cytokinetics Announces Data and Trial Design Presented at the International Symposium on ALS/MND
Dec 9, 2020 07:35AM Cytokinetics (CYTK) Announces Progression of REDWOOD-HCM to Cohort 2
Dec 9, 2020 07:30AM Cytokinetics Announces Progression of REDWOOD-HCM to Cohort 2
Dec 7, 2020 07:30AM Cytokinetics Announces Additional Results From GALACTIC-HF Presented at the 17th Global Cardiovascular Clinical Trialists
Dec 3, 2020 07:30AM Cytokinetics Announces Three Presentations at the International Symposium on ALS/MND
Dec 1, 2020 04:00PM Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Dec 1, 2020 07:30AM Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists Forum
Nov 24, 2020 04:00PM Cytokinetics to Participate in Upcoming Investor Conferences
Nov 23, 2020 07:33AM Cytokinetics (CYTK) Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen (AMGN)
Nov 23, 2020 07:30AM Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen
Nov 20, 2020 07:30AM Cytokinetics Names Nancy Wysenski to Board of Directors
Nov 16, 2020 07:35AM Cytokinetics (CYTK) Announces Preclinical Data for CK-3773274 and CK-3772271 Presented at the AHA
Nov 16, 2020 07:30AM Cytokinetics Announces Preclinical Data for CK-3773274 and CK-3772271 Presented at the AHA Scientific Sessions 2020
Nov 16, 2020 07:30AM Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at the AHA Scientific Sessions 2020
Nov 13, 2020 11:43AM Cytokinetics (CYTK) Announces Results From GALACTIC-HF Presented at Late Breaking Clinical Trial Session at the American Heart Association Scientific Sessions and Published in NEJM
View More Recent Stories View Older Stories